I.M. van der Lubben
- Pharmaceutical Science top 0.5%
- Molecular Biology
- Biomaterials top 5%
- Immunology top 10%
- Epidemiology
- Co-authors
- Hans E. JungingerGerrit BorchardJ. Coos VerhoefGideon KerstenMarjan M. FretzCoen BeuveryFrank KoningsHenk K. Koerten
- Topics
- Advanced Drug Delivery Systems (5 papers)RNA Interference and Gene Delivery (3 papers)Respiratory viral infections research (3 papers)
- Partner nations
- Netherlands
In The Last Decade
I.M. van der Lubben
8 papers receiving 962 citations
Peers
Comparison fields: 5 of 94
- Pharmaceutical Science 565
- Molecular Biology 333
- Biomaterials 253
- Immunology 233
- Epidemiology 143
Countries citing papers authored by I.M. van der Lubben
This map shows the geographic impact of I.M. van der Lubben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.M. van der Lubben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.M. van der Lubben more than expected).
Fields of papers citing papers by I.M. van der Lubben
This network shows the impact of papers produced by I.M. van der Lubben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.M. van der Lubben. The network helps show where I.M. van der Lubben may publish in the future.
Co-authorship network of co-authors of I.M. van der Lubben
This figure shows the co-authorship network connecting the top 25 collaborators of I.M. van der Lubben. A scholar is included among the top collaborators of I.M. van der Lubben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.M. van der Lubben. I.M. van der Lubben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The aetiology of community-acquired pneumonia and implications for patient management. | 28 |
| 2 | 25 | |
| 3 | 0 | |
| 4 | 191 | |
| 5 | Trimethyl chitosan chloride (TMC) as a novel excipient for oral and nasal immunisation against diphtheria | 6 |
| 6 | 56 | |
| 7 | 273 | |
| 8 | 354 | |
| 9 | 81 |
About I.M. van der Lubben
I.M. van der Lubben is a scholar working on Pharmaceutical Science, Emergency Medicine and Microbiology, having authored 9 papers that have together received 1.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), RNA Interference and Gene Delivery (3 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Pharmaceutical Science (565 citations), Biomaterials (253 citations) and Molecular Medicine (74 citations). I.M. van der Lubben has collaborated with scholars based in Netherlands. Frequent co-authors include Hans E. Junginger, Gerrit Borchard, J. Coos Verhoef, J. Coos Verhoef, Gideon Kersten, Marjan M. Fretz, Coen Beuvery, Frank Konings, Henk K. Koerten and Adam Meijer. Their work appears in journals such as Advanced Drug Delivery Reviews, Vaccine and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.